Overview
Behavioral and Pharmacological Treatment for Insomnia
Status:
Completed
Completed
Trial end date:
1969-12-31
1969-12-31
Target enrollment:
0
0
Participant gender:
All
All
Summary
This study will evaluate the long- and short-term effects of cognitive-behavior therapy (CBT), alone and in combination with zolpidem (Ambien®), for chronic insomnia.Phase:
Phase 4Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Laval UniversityCollaborator:
National Institute of Mental Health (NIMH)Treatments:
Zolpidem
Criteria
Inclusion criteria:- Subjective complaint of difficulties initiating or maintaining sleep, accompanied by
marked distress or daytime impairments due to insomnia
- Sleep difficulties present 3 nights or more per week and lasting for more than 6
months
Exclusion criteria:
- Major medical or psychiatric problems